Navigation Links
Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
Date:3/9/2010

September 12, Three Months Ended Year Ended 2002 December 31, December 31, (Inception) ------------- ------------- to December 31, 2009 2008 2009 2008 2009 ---- ---- ---- ---- ---- Revenues: Collaborative agreement $- $- $- $- $174 License revenue 22 22 88 88 441 --- --- --- --- --- Total revenues 22 22 88 88 615 Operating expenses: Research and development 8,862 17,526 47,441 79,261 216,559 General and administrative 5,923 4,602 18,177 15,651 55,999 ----- ----- ------ ------ ------ Total operating expenses 14,785 22,128 65,618 94,912 272,558 ------ ------ ------ ------ ------- Loss from operations (14,763) (22,106) (65,530) (94,824) (271,943) Other income
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... release its financial results for the fiscal 2014 fourth ... trading ends on Tuesday, September 9, 2014. ... p.m. U.S. EDT on Tuesday, September 9, 2014 (Wednesday, ... Company,s financial results, commercial partnerships, and future outlook.  The ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014  Abaxis, Inc. ... manufacturing point-of-care blood instrumentation and consumables to the medical, ... Severson , Chairman and Chief Executive Officer, will present ... Ideas Conference 2014 on Tuesday, September 9, 2014 at ... the Omni Berkshire Place Hotel in New ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2
... Colo., Oct. 7 Waleed Danho, Ph.D., Distinguished Research ... 2009 recipient of the Meienhofer Award for excellence in ... RCCPS ( http://www.rochecolorado.com/PeptideSymp09/ ). Hosted ... Boulder, RCCPS is the only global conference exclusively dedicated ...
... Biomedical Corporation, a leading developer of whole blood analyzers, ... Sanvita CBGM, LLC, has completed the acquisition of certain ... Inc. , Nova Biomedical is the sole ... Monitoring (CBGM) subsidiary has become the exclusive distributor, of ...
Cached Medicine Technology:Roche Scientist Recognized for Excellence in Peptide Chemistry 2Roche Scientist Recognized for Excellence in Peptide Chemistry 3Roche Scientist Recognized for Excellence in Peptide Chemistry 4Subsidiary of Nova Biomedical Completes Acquisition of Assets of CCS Medical's Subsidiary, Sanvita, Inc. 2
(Date:8/30/2014)... Serving contented clients since inception, #1 web design ... is now offering discount for Labor Day on all ... putting forward the best of web development technology before ... of professionals and web developers and designers has expertise ... critical issues of web development and can develop websites ...
(Date:8/30/2014)... 2014 The federal judge overseeing ... http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston Scientific Corp. has ... selected for one of the proceeding’s bellwether trials. ... 2014, U.S. District Judge Joseph R. Goodwin of ... Boston Scientific’s contention that a consolidated trial would ...
(Date:8/30/2014)... Transvenous lead extraction (TLE) is clinically successful in more ... European Lead Extraction ConTRolled (ELECTRa) registry presented for the ... Maria Grazia Bongiorni, chair of the registry,s executive committee. ... electronic devices (CIED) implant procedures has grown in recent ... has increased and leads are often the cause. TLE ...
(Date:8/30/2014)... OK (PRWEB) August 30, 2014 In ... valuable, and increasingly difficult to get. Snoring and sleep ... sleep and breathing stops) robs people and their bed ... daily challenges. Up to 45% of the population snores ... have sleep apnea. Of these, only 10% have been ...
(Date:8/30/2014)... Top10BestSEOHosting.com is a well-known review website. Recently, the ... http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the best Windows Hosting supplier ... that Bluehost and Arvixe are excellent companies for ... Top 10 Web Hosting in 2014, is a ... offers rich features and great Windows hosting solutions ...
Breaking Medicine News(10 mins):Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2
... available in German . The stomach bacterium ... the development of gastric cancer, the third most common cause of ... Zurich have now identified a mechanism of Helicobacter pylori that damages ... up for malignant transformation. Gastric cancer is one of the ...
... Do sexualized lyrics in popular music have an impact on ... Joshua H. West, and Shane Hill from Brigham Young University ... increasing use of sexually explicit lyrics in music. Their ... , provide food for thought for educators whose focus is ...
... Academy of Sciences and the Global Medical Excellence Cluster ... College London, will host a two-day scientific conference, ... and Toxicity," that will provide a forum to ... drug discovery. Areas of focus include: how do animal ...
... published study by researchers at Columbia University,s Mailman School ... effects on children of a group of ubiquitous chemicals ... that are known to disrupt the endocrine system, and ... toys, to household building materials, to shampoos. Recent ...
... News) -- Mild cognitive impairment -- marked by a ... a stronger predictor of Alzheimer,s disease than so-called "biomarkers," ... or levels of certain proteins in cerebrospinal fluid, a ... people with mild cognitive impairment (MCI) who developed Alzheimer,s ...
... French . , A major landmark study released ... light on the state of Europe,s mental and neurological health. ... largest health challenge in the 21st century. The study also ... together with the large and increasing number of ,disorders of ...
Cached Medicine News:Health News:Stomach bacterium damages human DNA 2Health News:Songs about sex - how they affect kids 2Health News:New York Academy of Sciences and GMEC host forum on value of animal models in drug discovery 2Health News:New York Academy of Sciences and GMEC host forum on value of animal models in drug discovery 3Health News:Prenatal exposure to phthalates linked to decreased mental and motor development 2Health News:Short-Term Memory Loss May Be Best Predictor of Alzheimer's 2Health News:The size and burden of mental disorders in Europe 2Health News:The size and burden of mental disorders in Europe 3
Titanium. Curved shafts with 5.5 mm tying platform. Round knurled handle with dull finish. Overall length 4.3 inches....
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Angled 45 degree shafts 8 mm from tip to bend with 4 mm tying platform. Smooth handle with dull finish. Overall length 3.2 inches....
Straight shafts with 4 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches....
Medicine Products: